Roi Weiser

Surgical Oncology

1515 Holcombe Blvd
Houston, TX 77030

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

ASO Visual Abstract: The Role of Adjuvant Primary Site Radiotherapy for Patients with Cutaneous Melanoma with Microsatellitosis.

ASO Visual Abstract: The Role of Adjuvant Primary Site Radiotherapy for Patients with Cutaneous Melanoma with Microsatellitosis.

Journal: Annals of surgical oncology

Published: June 01, 2026

Correction: Real-World Outcomes for Patients with Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal Dissection.

Correction: Real-World Outcomes for Patients with Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal Dissection.

Journal: Annals of surgical oncology

Published: April 24, 2026

The Role of Adjuvant Primary Site Radiotherapy for Cutaneous Melanoma Patients with Microsatellitosis.

The Role of Adjuvant Primary Site Radiotherapy for Cutaneous Melanoma Patients with Microsatellitosis.

Journal: Annals of surgical oncology

Published: January 08, 2026

Germline variants in cancer susceptibility genes among patients with mucosal melanoma.

Germline variants in cancer susceptibility genes among patients with mucosal melanoma.

Journal: NPJ genomic medicine

Published: September 12, 2025

Surgical Reconstruction Toxicity Following Hypofractionated Adjuvant Radiation Therapy for Primary Cutaneous Melanoma.

Surgical Reconstruction Toxicity Following Hypofractionated Adjuvant Radiation Therapy for Primary Cutaneous Melanoma.

Journal: Practical radiation oncology

Published: August 07, 2025

Real-World Outcomes for Patients with Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal Dissection.

Real-World Outcomes for Patients with Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal Dissection.

Journal: Annals of surgical oncology

Published: August 01, 2025

Systemic Therapy for Melanoma: What Surgeons Need to Know.

Systemic Therapy for Melanoma: What Surgeons Need to Know.

Journal: Surgical oncology clinics of North America

Published: May 24, 2025

The Era "or Error" of Second Localization Procedures.

The Era "or Error" of Second Localization Procedures.

Journal: The breast journal

Published: November 21, 2024

Clinical Outcomes for BRCA Pathogenic Variant Carriers With Breast Cancer Undergoing Breast Conservation.

Clinical Outcomes for BRCA Pathogenic Variant Carriers With Breast Cancer Undergoing Breast Conservation.

Journal: JAMA network open

Published: June 25, 2024

Durable local control with hypofractionated radiation therapy for unresectable or metastatic melanoma.

Durable local control with hypofractionated radiation therapy for unresectable or metastatic melanoma.

Journal: Clinical and translational radiation oncology

Published: May 30, 2024

Outcomes of patients with resected stage III/IV acral or mucosal melanoma, treated with adjuvant anti-PD-1 based therapy.

Outcomes of patients with resected stage III/IV acral or mucosal melanoma, treated with adjuvant anti-PD-1 based therapy.

Journal: European journal of cancer (Oxford, England : 1990)

Published: October 22, 2023

De-escalation of Post-mastectomy Irradiation in Hormone Receptor-Positive Breast Cancer with One to Three Positive Nodes.

De-escalation of Post-mastectomy Irradiation in Hormone Receptor-Positive Breast Cancer with One to Three Positive Nodes.

Journal: Annals of surgical oncology

Published: May 17, 2023

Showing 1-12 of 30

Last Updated: 09/26/2026